Lilly BioMedicines Head Ricks Tasked With Overseeing Growth Phase As Next CEO
Long-time CEO John Lechleiter, who led the company through a challenging period of enormous patent expirations, will step down at year's end.
Long-time CEO John Lechleiter, who led the company through a challenging period of enormous patent expirations, will step down at year's end.